# Haleon plc: financial statements, quarterly

HLN · NYSE · CIK 1900304 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hln.md) · [Financials](/companies/hln/financials.md) · [Filings](/companies/hln/filings.md) · [Insiders](/companies/hln/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hln/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2019-12-31) | period not labelled (2020-12-31) | period not labelled (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | [0.3](/filings/0001558370-23-004167.md) | [0.4](/filings/0001558370-24-003331.md) | [0.7](/filings/0001558370-25-003368.md) | [1.0](/filings/0001104659-26-027443.md) | [2.3](/filings/0001104659-26-027443.md) | [1.3](/filings/0001104659-26-027443.md) |
| Current assets | $bn | not reported | not reported | [5.3](/filings/0001558370-23-004167.md) | [4.1](/filings/0001558370-24-003331.md) | [4.8](/filings/0001558370-25-003368.md) | [5.7](/filings/0001104659-26-027443.md) | [4.6](/filings/0001104659-26-027443.md) |
| Total assets | $bn | not reported | not reported | [34.5](/filings/0001558370-23-004167.md) | [34.8](/filings/0001558370-24-003331.md) | [34.1](/filings/0001558370-25-003368.md) | [34.3](/filings/0001104659-26-027443.md) | [32.6](/filings/0001104659-26-027443.md) |
| Current liabilities | $bn | not reported | not reported | [4.2](/filings/0001558370-23-004167.md) | [4.4](/filings/0001558370-24-003331.md) | [4.6](/filings/0001558370-25-003368.md) | [5.8](/filings/0001104659-26-027443.md) | [4.9](/filings/0001104659-26-027443.md) |
| Total liabilities | $bn | not reported | not reported | [8.0](/filings/0001558370-23-004167.md) | [18.4](/filings/0001558370-24-003331.md) | [17.3](/filings/0001558370-25-003368.md) | [18.1](/filings/0001104659-26-027443.md) | [16.1](/filings/0001104659-26-027443.md) |
| Shareholders' equity | $bn | [27.4](/filings/0001558370-23-004167.md) | [26.2](/filings/0001558370-24-003331.md) | [26.4](/filings/0001558370-23-004167.md) | [16.3](/filings/0001558370-24-003331.md) | [16.6](/filings/0001558370-25-003368.md) | [16.2](/filings/0001104659-26-027443.md) | [16.4](/filings/0001104659-26-027443.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 8,952,353,648 at 2026-03-13, from the cover of the [20-F filed 2026-03-13](/filings/0001104659-26-027443.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.